Idiopathic pulmonary fibrosis is impacting the lives of as many as 132,000 Americans. With no known cause and limited disease management options, IPF is a devastating disease for patients to live with.

Through the powerful stories of patients and celebrities, this documentary takes an up close look at a disease that most people have never heard of.

Watch the Trailer | Watch the Show

Featured Experts:

Gregory P. Cosgrove, MD, FCCP
Associate Professor, Pulmonary and Critical Care
National Jewish Health, Denver

Gregory Cosgrove, MD, is a member of the Interstitial Lung Disease Program at National Jewish Health in Denver and an active participant in its clinical and research programs. A graduate of Hahnemann University School of Medicine, he completed his residency in Internal Medicine at Thomas Jefferson University Hospital and a fellowship at University of Colorado, Denver, in Pulmonary and Critical Care Medicine. At National Jewish Health in Denver, Dr. Cosgrove is Assistant Director of the Interstitial Lung Disease Program and is conducting research focused on the basic cellular and molecular mechanisms involved in the lung’s response to injury and predisposition to fibroproliferation. Dr. Cosgrove is Chief Medical Officer with the Pulmonary Fibrosis Foundation and is included in the “Best Doctors in America” list.

Kevin F. Gibson, MD
Clinical Director, University of Pittsburgh
Dorothy P & Richard P Simmons Center for Interstitial Lung Disease
UPMC Montefiore Hospital

Kevin F. Gibson, MD, is an associate professor of medicine in the Division of Pulmonary, Allergy, and Critical Care Medicine and assistant professor in the Department of Neurobiology, Anatomy, and Cell Sciences at the University of Pittsburgh School of Medicine. A graduate of UMDNJ-Rutgers Medical School, Dr. Gibson completed an internship and residency in internal medicine at Emory University Affiliated Hospitals in Atlanta, Ga., and pulmonary medicine and research fellowships at the University of Pittsburgh. He is board-certified in internal medicine, pulmonary medicine, and critical care medicine and has written 30 abstracts and articles. Dr. Gibson currently serves as president of the Association for Respiratory Health of Minorities.

Erica L. Herzog, MD, PhD
Associate Professor of Pulmonary Medicine
Director, Yale Interstitial Lung Disease Center of Excellence
Yale School of Medicine, New Haven

Erica Herzog, MD, PhD, is a Pulmonary Specialist and is the Director of the Interstitial Lung Disease Center of Excellence at Yale School of Medicine. Dr. Herzog received her Bachelor's and MD degrees from the University of North Carolina at Chapel Hill. After her residency in Internal Medicine at Mount Sinai Medical Center in New York, she came to Yale to pursue a fellowship in Pulmonary and Critical Care Medicine where she also received her PhD in Investigative Medicine from Yale's graduate school of arts and sciences. Dr. Herzog maintains an active clinical practice caring for patients with chronic pulmonary conditions, and performs basic and translational research aimed at developing preventative and treatment strategies for patients with interstitial lung disease.

Mark P Steele, MD
Professor of Medicine, Department of Medicine
Allergy, Pulmonary and Critical Care
Vanderbilt University Medical Center, Nashville

Mark P. Steele, MD, is a Pulmonologist, Allergist and Immunologist with 28 years of experience. He graduated in Medicine from the University of Illinois in Chicago with his residency in an affiliated hospital. Dr. Steele currently teaches and practices at Vanderbilt University Hospital in Internal Medicine, Pulmonary Disease, Critical Care Medicine, Allergy & Immunology and Clinical Genetics with special expertise in interstitial lung diseases and pulmonary fibrosis. Dr. Steele’s present research includes the investigation of inherited genetic factors that play a role in the development of familial pulmonary fibrosis and in identifying a group of genes that predispose individuals to develop pulmonary fibrosis.

Every Breath Counts was produced by Summer Productions in collaboration with the Pulmonary Fibrosis Foundation and Coalition for Pulmonary Fibrosis. Financial support and other expertise for Every Breath Counts was provided by Boehringer Ingelheim.